Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haeck

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Acta Dermato-Venereologica|June 19, 2025
Real-world Cost per Responder Among Different Classes of Biologics for the Treatment of PsoriasisLinda T H Godding, Marieke M B Seyger, Albert Duvetorp, et al.
Journal of Psoriasis and Psoriatic Arthritis|April 4, 2025
Lower Drug Survival, Less Satisfaction and More Adverse Events in Females Using Biologics for Psoriasis: Results of the Dutch BioCAPTURE RegistryLiana Barenbrug, Renate G van der Molen, Jake S F Maurits, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Acta Dermato-Venereologica|June 19, 2025
Real-world Cost per Responder Among Different Classes of Biologics for the Treatment of PsoriasisLinda T H Godding, Marieke M B Seyger, Albert Duvetorp, et al.
Journal of Psoriasis and Psoriatic Arthritis|April 4, 2025
Lower Drug Survival, Less Satisfaction and More Adverse Events in Females Using Biologics for Psoriasis: Results of the Dutch BioCAPTURE RegistryLiana Barenbrug, Renate G van der Molen, Jake S F Maurits, et al.
Pageof 4